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Background: This study aimed to determine the relationship between dyslipidemia and dry eye disease (DED) in a
Korean population.
Methods: This population-based study enrolled 5,627 adults (aged >19 years) who were participating in the first
year of the fifth annual Korea National Health and Nutrition Examination Survey from 2010 to 2011. Clinically
diagnosed DED and its symptoms were surveyed, and biochemical blood analysis data were collected. Dyslipidemia
was defined as any of the following: hypercholesterolemia (total cholesterol > 200 mg/dL), hypertriglyceridemia
(triglyceride > 150 mg/dL), low levels of high-density lipoprotein (<40 mg/dL), or high levels of low-density
lipoprotein (>100 mg/dL).
Results: After adjusting for demographics (age and body mass index), lifestyle (smoking, drinking, exercise, and
residential district), and medical factors (diabetes, hypertension, previous ophthalmic surgery, menopause, and
rheumatologic disease), elevated serum cholesterol level was found to be associated with increased likelihood of
DED (odds ratio, 1.77; 95% confidence interval, 1.127–2.78) in women.
Conclusions: DED in a Korean population was found to be associated with high serum cholesterol levelsThe results
of this study highlight the significance of eye examinations and independent lipid profile monitoring in patients
with dyslipidemia because of its possible correlation with DED progression.
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The lipid layer is an essential component of the tear film,
which maintains a smooth corneal surface and controls
the evaporation rate from the eye [1]. The tear film lipid
layer is composed chiefly of the meibomian glands, which
are tubuloacinar holocrine glands that discharge their
entire contents during the secretion process [2]. Chemical
analysis of lipids secreted from normal meibomian glands
shows that it consists of a mixture of non-polar lipids
(wax esters, cholesterol, and cholesterol esters) and polar
lipids (phospholipids and glycolipids) [3]. Systemic dys-
lipidemia, a disorder of lipid metabolism, may theoretically
affect the meibomian lipid composition.* Correspondence: drna@catholic.ac.kr
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reproduction in any medium, provided the orDyslipidemia is one of the significant modifiable risk fac-
tors for cardiovascular diseases [4]. Total cholesterol (TC)
is composed of 3 main types of lipoproteins—low-density
lipoprotein (LDL), high-density lipoprotein (HDL), and
very-low-density lipoprotein (VLDL) [4,5]. The association
between elevated LDL cholesterol (LDL-C) and increased
risk for cardiovascular events is well established [6], and
other lipid parameters are also predictive of cardiovascular
risk, including high non-HDL [4], low HDL [7], and ele-
vated triglyceride (TG) levels [8].
Dry eye disease (DED) is a multifactorial disorder of
the tears and the ocular surface that results in symptoms
such as ocular discomfort, visual disturbance, and tear
film instability with potential damage to the ocular
surface [9]. Although the importance of the lipid layer in
tear composition is well accepted, there is little informa-
tion about whether dyslipidemia resulting from systemic
lipid disorder is related to DED. Some epidemiologic
data have reported conflicting results about such antd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that lacrimal gland structure and function were differen-
tially affected by changes in the lipid profile in mice
[14]. A case–control study concluded that patients with
moderate to severe meibomian gland disease (MGD), a
major cause of evaporative DED, have a higher incidence
of dyslipidemia with respect to elevated TC than the
general population [12]. On the other hand, one pro-
spective cohort study showed that although the presence
of MGD does not correlate with dyslipidemia, the pre-
valence of high TG and LDL increases with increasing
severity of MGD [13]. To make a more definite assess-
ment of the association between dyslipidemia and DED,
we assessed the data from the Korean National Health
and Nutrition Examination Survey (KNHANES). Detailed
data on lipid profile and DED were examined in the
current study to determine the association between DED
and dyslipidemia.Methods
Study subjects and procedures
This cross-sectional study included a representative
sample of the data gathered during the KNHANES V,
which was performed from 2010 to 2011 by the Division
of Chronic Disease Surveillance under the Korea Centers
for Disease Control and Prevention.
The sampling units were registry households selected
through a stratified multistage probability sampling
based on geographic area, sex, and age group. Informa-
tion was collected from stratified multistage probability
samples of Korean households representing the non-
institutionalized civilian population. The survey was com-
posed of 3 parts, that is, a health interview survey, health
examination survey, and nutrition survey, and it was a
nationwide representative study of non-institutionalized
civilians involving a stratified multistage probability sam-
pling design using a rolling survey sampling model. Sam-
pling units were defined based on household unit data
from the 2010 National Census Registry, including those
for geographic area, sex, and age.
Institutional review board/ethics committee approvals
were obtained from the Catholic University of Korea in
accordance with the Declaration of Helsinki. The data
used here are publicly available from the Korean Centers
for Disease Control and Prevention [15]. Written infor-
med consent was obtained from the patient for publica-
tion of this report and any accompanying images.
Questionnaires were used to collect demographic in-
formation, residential district (urban, rural), smoking
history, educational status, alcohol consumption, me-
dical history, and any use of prescription or nonpres-
cription medications. Residential area was measured as
urban versus rural, and urban included both large andsmall cities. Education level was measured according to
3 categories: less than high school, high school, and
some college or higher. Household income was mea-
sured as quartiles based on inflation-adjusted per capita
household income, which we used to classify individuals
as being in the highest, middle-high, middle-low, and
lowest quartiles. Based on the smoking behavior, indivi-
duals were categorized as current smokers, ex-smokers,
or nonsmokers. Based on alcohol consumption, indivi-
duals were classified as nondrinkers, mild-to-moderate
drinkers (1.0–30.0 g alcohol/day), or heavy drinkers
(>30.0 g alcohol/day) after conversion of the average
frequency and amount of alcoholic beverages consumed
into the amount of pre-alcohol (in grams) consumed per
day. Physical activity was divided into 3 groups accor-
ding to frequency of exercise: ≤1 time per week, 2–3
times per week, and ≥4 times per week. KNHANES
adopted the International Physical Activity Questionnaire
to determine physical activity frequency. Menopause was
defined as the participant’s self-reported menopause status
or having had an hysterectomy.
Anthropometric measurements of the subjects were
made by a specially trained examiner. Waist circumfer-
ence was measured to the nearest 0.1 cm in a horizontal
plane at the level of the midpoint between the iliac crest
and the costal margin at the end of a normal expiration.
Body mass index (BMI) was calculated as the individual’s
weight in kilograms divided by the square of the indivi-
dual’s height in meters. Systemic hypertension was
defined as a measured systolic blood pressure of >160 mm
Hg or a diastolic blood pressure of >90 mm Hg or the
current use of systemic antihypertensive drugs.
Peripheral blood was obtained from each subject after
fasting for at least 8 hours. Serum TC, HDL, and TG con-
centrations were enzymatically measured using a Hitachi
Automatic Analyzer 7600 (Hitachi/Japan) with reagents
(Pureauto SCHO-N, DAIICHI/Japan; CHOLESTEST N
HDL, DAIICHI/Japan; Pureauto S TG-N, DAIICHI/Japan)
by the NEODIN Medical Institute. The LDL-C concentra-
tion was calculated using the Friedewald equation (LDL −
C =TC − [HDL-C + {TG ÷ 5}]) [16]. The prevalence of
dyslipidemia was assessed according to the AHA and
NECP-III report [17,18]. The cut-off value of dyslipidemia
was any of the following: hypercholesterolemia (TC ≥
200 mg/dL); hypertriglyceridemia (TG ≥ 150 mg/dL);
low HDL (<40 mg/dL); or high LDL (≥100 mg/dL).
Diabetes was defined as a measured fasting blood
sugar of >126 mg/dL or current use of antidiabetic
medication.
A DED questionnaire survey was conducted that
included the following yes/no questions: (1) Have your
eyes felt dry recently? and (2) Have you ever been diag-
nosed by an ophthalmologist as having DED? DED was
defined as clinically diagnosed DED.
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The data are expressed as numbers and percentages
(categorical) or mean ± standard error (continuous).
Multivariable adjusted logistic regression analysis was
conducted to examine the odds ratio (OR) and 95%
confidence interval (CI) for the association of DED with
TC, TG, HDL, and LDL. Age, education, residential area,
smoking history, alcohol consumption, BMI, waist cir-
cumference, menopausal history (women), hypertension,
and diabetes were used as covariates for calculating the
adjusted OR.
Because the KNHANES V included weights to com-
pensate for its complex sampling design and to allow
approximations of the Korean population, weighted ana-
lyses were performed using SAS software (version 9.2;
SAS Institute, Cary, NC, USA). Values of p < 0.05 were
considered statistically significant.Table 1 Baseline characteristics of demographic, lifestyle, and
eye diseses
Male
Non-DED (n = 2292) DED (n = 1
Age (years) 44.2 ± 0.5 47 ± 1.9
Residential district (% rural) 21.8(3.3) 22.2(5.3
Monthly income (% lowest quartile) 14.9(1.1) 13.3(3.8
Education (% some college≥) 36.7(1.6) 37.9(5.7
BMI (kg/m2) 24 ± 0.1 23.8 ± 0.
Waist circumference (cm) 84.9 ± 0.9 84.2 ± 0.
Smoker (%) 42.3(1.2) 39.8(5.7
Heavy-drinker (%) 18.2(0.9) 13.3(3.7
Exercise (% yes) 25.7(1.2) 23.8(5)
Menopause (% yes) NA NA
Symptoms of DED (% yes) 8(1) 81.3(4.7
Diabetes (% yes) 11(0.9) 10.9(3.3
Hypertension (% yes) 31(1.5) 27.3(5.7
Rheumatoid arthritis history (% yes) 1.6(0.4) 1.4(1.1)
Any ophthalmic surgery (% yes) 7.8(0.6) 24.6(5.1
Mean SBP (mmHg) 122 ± 0.5 121.2 ± 1
Mean DBP (mmHg) 80.4 ± 0.4 78.7 ± 0.
Laboratory data
Glucose (mg/dL) 98.2 ± 0.7 98.1 ± 1.
Insulin (uIU/mL) 10.4 ± 0.1 9.9 ± 0.4
Total cholesterol (mg/dL) 187.2 ± 1 184.5 ± 3
Triglycerides (mf/dL) 157.4 ± 3.9 134 ± 9.7
HDL 49.6 ± 0.3 51.5 ± 1.
LDL 112.3 ± 0.9 110.4 ± 3
Values are represented as means ± SD. Numbers in brackets represent percentages
DED = dry eye disease; BMI = Body mass index; SBP = systolic blood pressure; DBP =
LDL = low-density lipoprotein.Results
Since Korea is a single-race nation, all of the subjects
were Asian. Among 8,958 subjects in the first year of the
KNHANES V, 8,141 (90.88%) underwent an ophthal-
mologic examination. We excluded the 1,858 who were
aged <19 years, 449 whose DED data were missing, and
207 who had a blood test without an 8-hour fast. Of the
remaining 5,627 individuals (2,408 men, 3,219 women),
116 men (5.06%) and 415 women (14.80%) were clini-
cally diagnosed with DED.
The baseline characteristics of the study participants
according to gender and DED are presented in Table 1.
We found a significantly higher proportion of non-DED
women residing in rural areas (p = 0.007). DED symp-
toms were more frequent in the DED group, both in
men (p < 0.0001) and women (p < 0.0001). Both male
(p < 0.0001) and female (p < 0.0001) subjects in the DEDmedical factors of subjects according to gender and dry
Female
16) P-value Non-DED (n = 2804) DED (n = 415) P-value
0.2729 46.2 ± 0.5 44.9 ± 1.1 0.1566
) 0.9171 23.4(3.5) 14.4(3.1) 0.0007
) 0.6809 19.3(1.2) 18.4(2.5) 0.7324
) 0.8314 28.9(1.4) 28.7(2.9) 0.9368
3 0.0156 23.3 ± 0.1 22.7 ± 0.2 0.5919
9 0.0063 78.1 ± 0.3 76.4 ± 0.6 0.593
) 0.648 5.5(0.6) 3.6(1.3) 0.2473
) 0.2571 1.8(0.3) 1.5(0.9) 0.7757
0.7217 20.3(1.1) 16(2.4) 0.1141
NA 35.5(1.5) 38.3(3.1) 0.4255
) <.0001 12.1(1.1) 81.4(3) <.0001
) 0.9851 9.1(0.8) 8.9(1.6) 0.8944
) 0.5244 46.5(1.4) 48.3(3.3) 0.6178
0.8616 3.1(0.4) 3.2(0.9) 0.9261
) <.0001 13.5(0.8) 24.1(2.4) <.0001
.7 0.3422 117.4 ± 0.6 116.3 ± 1 0.6275
9 0.8309 74.3 ± 0.3 74.2 ± 0.5 0.0868
9 0.8866 94.3 ± 0.5 94.1 ± 1.2 0.9478
0.375 10.5 ± 0.1 10.1 ± 0.2 0.3519
.4 0.6799 186.7 ± 0.9 185.8 ± 2.2 0.4302
0.721 109.3 ± 2 106.2 ± 4 0.1337
5 0.6395 56 ± 0.3 56.3 ± 0.7 0.2197
.3 0.8224 113.9 ± 0.7 113.4 ± 1.9 0.5698
(standard error).
diastolic blood pressure; HDL = high-density lipoprotein;
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ous ophthalmic surgical history. The prevalence of DED
was higher in men with a low BMI and small WC.
In patients with DED stratified according to the age
group (20–65 and >65 years), there were statistically sig-
nificant differences in the prevalence of high cholesterol
and LDL between female patients with DED aged
>65 years and normal female control subjects. Statis-
tically significant differences in high cholesterol preva-
lence were also seen among those aged 20–65 years
(Figure 1).
We detected some differences in prevalence after strati-
fication according to different combinations of independ-
ent lipid profiles. The prevalence of the 3 combinations,
hypercholesterolemia + hypertriglyceridemia, hypercholes-
terolemia + high LDL-C, and hypercholesterolemia +
hypertriglyceridemia + high LDL-C, were significantly dif-
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Figure 1 Prevalence of dyslipidemia with respect to TC, HDL, LDL, an
by age in male (A) and female (B). There were statistically significant diff
levels between female DED patients aged >65 years and those without DE
20–65 years were also statistically significant. TC, total cholesterol; HDL, hig
DED, dry eye disease. *Statistically significant difference between the 2 gro
hypercholesterolemia (TC≥ 200 mg/dL), hypertriglyceridemia (TG ≥150 mg
LDL (≥100 mg/dL).Univariate analysis revealed that the lipid profile
factors associated with clinically diagnosed DED were
high cholesterol. There was a statistically smaller per-
centage of low HDL in female diagnosed DED and who
has symptoms of DED, when compare to control
(Table 2).
After adjustment for demographics (age, BMI), lifestyle
(smoking, drinking, exercise, and residential district),
and medical factors (diabetes, hypertension, previous
ophthalmic surgery, menopause, and rheumatologic
disease), the prevalence of DED was calculated by gen-
der, and each calculated OR had a 95% CI with respect
to lipid profiles. The lipid profile associated with in-
creased likelihood of DED was elevated cholesterol level
(OR, 1.77; 95% CI, 1.127–2.78) in women (Table 3).
Discussion
To our knowledge, the current study is the first population-
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ups. The cut-off value for dyslipidemia was any of the following:


































































Figure 2 Comparison of the prevalence (%) of different combinations of dyslipidemia in patients with dry eye disease (DED) and those
without DED. A, male subject; B, female subject; DED ■; non-DED (gray circle), C, hypercholesterolemia (total cholesterol ≥ 200 mg/dL); T,
hypertriglyceridemia (triglyceride ≥150 mg/dL); H, low high-density cholesterol (HDL) < 40 mg/dL; L, high low-density cholesterol (LDL)≥ 100 mg/dL. *
Statistically significant difference between the 2 groups. The definition of dyslipidemia was the prevalence of any of the following conditions:
hypercholesterolemia (TC≥ 200 mg/dL); hypertriglyceridemia (TG≥ 150 mg/dL); low HDL (<40 mg/dL); or high LDL (≥100 mg/dL).
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pared to normal female controls. Earlier reports of
dyslipidemia and DED showed conflicting results.
One retrospective control study of 66 patients
concluded that patients with moderate to severe MGD
had a higher incidence of dyslipidemia with respect to
elevated cholesterol than the general population as
reported by data from the National Health and Nutrition
Examination Survey (NHANES) [12]. When stratified
according to gender, only men aged 20–44 and 45–
64 years showed a statistically different levels of hyper-
cholesterolemia. They found the component of total
cholesterol that contributed most to increase in total
cholesterol came from elevated serum HDL levels. This
study has some limitations due to its relatively small
sample size and an overall population that was older
than the normal population in the NHANES. Moreover,
menopausal history, which greatly affects the develop-
ment of DED, was lacking in the NHANES.
Another Taiwan population-based study also found
that the prevalence of hyperlipidemia was significantly
higher in patients with DED [11]. After adjusting gender,
age, and socioeconomic status, they showed that com-
pared to normal control, patients with DED had a
greater tendency to have hyperlipidemia.
Unlike these results, in the Beaver Dam Eye study,
Moss et al. found that the incidence of DED was notsignificantly associated with serum total cholesterol,
HDL, or cardiovascular diseases after controlling age
and gender in population-based cohort [10].
The current study revealed that only female patients
with DED had a statistically higher prevalence of hyper-
cholesterolemia. The reason hypercholesterolemia occurs
in the presence of DED can be explained as increased
cholesterol in the meibomian lipid would increase its
melting point to 46°C versus the normal meibomian lipid
melting point of 30–34°C and, thus, lead to increased
viscosity and plugging of the meibomian orifice [19].
Interestingly, we found that low HDL was more preva-
lent in female subjects with controls than that in female
with DED, which was statistically significant. It is quite
surprising that HDL, which is well known for its
preventive effect in cardiovascular disease, may acts
negatively in the presence of DED. Among female sub-
jects, none of the combinations with low HDL-C dem-
onstrated significant differences in prevalence between
the DED and non-DED groups, whereas every combi-
nation without high HDL-C showed significant differ-
ences. This finding may explain the opposing effects of
HDL in DED development and cardiovascular diseases.
The mechanism why elevated HDL may be a risk factor
for the development of MGD despite its cardioprotective
role is not clear. Meibomian glands, a modified form of
sebaceous glands, are reported to be uniquely related to




No Yes P-value No Yes P-value
Hypercholesterolemia 11.3(0.8) 8(3) 0.351 11.7(0.7) 16.2(2.3) 0.033
Hypertriglycemia 21.5(1.2) 20.3(5.6) 0.8313 9.5(0.7) 9.6(1.7) 0.9595
Low HDL 33.5(1.4) 33.6(5.4) 0.9909 15.8(0.9) 11.7(1.7) 0.0461
High LDL 11.4(0.9) 8.5(3) 0.413 11.8(0.7) 15.7(2.5) 0.0921
Symptoms of DED
Male Female
No Yes P-value No Yes P-value
Hypercholesterolemia 10.8(0.8) 12.6(2.5) 0.4816 11.8(0.8) 14.8(1.7) 0.095
Hypertriglycemia 21.4(1.3) 25(3.8) 0.3326 9.6(0.8) 8.9(1.4) 0.6573
Low HDL 33.3(1.4) 29.7(3) 0.2591 16.3(1.1) 11.6(1.5) 0.0215
High LDL 11.1(1) 12(2.4) 0.7271 12(0.7) 14.8(1.8) 0.1232
Data are expressed as percentage (standard error).
Φ The cut-off value of dyslipidemia was as any of the following : hypercholesterolemia (TC ≥ 200 mg/dL); hypertriglycemia (TG ≥150 mg/dL); low HDL, <40 mg/dL;
or high LDL ≥ 100 mg/dL.
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acyl-CoA:cholesterol acyltransferase (ACAT) catalyzes
the esterification of cellular cholesterol, which is subse-
quently secreted into the circulation in the form of
lipoproteins [20]. A murine model study showed that
HDL and VLDL markedly enhanced sebaceous epithelial
cell differentiation, which is defined by the increasing
accumulation of lipid droplets, the major component of
sebum [20]. The absence of ACAT-1 was shown to at-
tenuate atherosclerosis but cause meibomian gland atro-
phy and cutaneous xanthomatosis in a mouse model [21].
One randomized trial of healthy male and female sub-
jects reported that simvastatin, which reduces blood
cholesterol levels, was associated with meibomian gland
obstruction and skin sebaceous gland hypotrophy [22].Table 3 Odds ratio (95% CI) on multivariate analysis for anlal










The cut-off value of dyslipidemia was as any of the following : hypercholesterolemi
high LDL ≥ 100 mg/dL.
† Model1 = Adjusted for demographic factors (age, and body mass index)
‡ Model2 = Model1 + adjusted for lifestyle factors (smoking, drinking, exercise, and
§ Model3 = Model 2 + adjusted for medical factors (diabetes, hypertension, previousHDL transports cholesterol from the tissues to the liver
to be disposed, making it beneficial for cardiovascular
disease; however, it is plausible that HDL stimulates lipid
production within the meibomian gland to alter its melt-
ing point and decrease its viscosity.
In the current study, MGD was not assessed in
patients with DED, so it may include a combination of
DED types. However, the International Workshop on
Meibomian Gland Dysfunction has reported a striking
feature that the prevalence of MGD appeared to be
higher in studies on Asian populations [23]: 46.2% in a
Bangkok study [24], 60.8% in the Shipai Eye Study [25],
61.9% in a Japanese study [26], and 69.3% in the Beijing
Eye study [27]. Although the nationwide prevalence of
MGD has not yet been reported in Korea, we assumeyzing association between lipid profiles and dry eye







a (TC ≥ 200 mg/dL); hypertriglycemia (TG ≥150 mg/dL); low HDL, <40 mg/dL; or
residential district)
ocular surgery, menopause, and rheumatologic diseases).
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clinically diagnosed DED also have MGD, considering
the previous epidemiologic studies in Asia.
Our study has some potential limitations. The
KNHANES data were not collected for ophthalmologic
evaluation; hence, much of the information was self-
reported and recall bias may exist. Additionally, no
objective diagnostic testing of dry eye was performed.
However, with regard to public health, subjective
methods such as these are valuable for DED studies
because symptoms directly affect the quality of life [9].
The strengths of this study are that it is the first large
population-based study in Korea and that it elucidated
the relationship between dyslipidemia and DED. In
addition, the anthropometric measurements and dia-
betes and hypertension diagnoses were made by trained
examiners and physicians in contrast to earlier studies,
which based this information on self-reporting. Finally,
since Koreans have relatively uniform genetic and envi-
ronmental influences including a single race, climate,
and food culture, our results may be more consistent
than those of other large population-based studies.
There have been few studies in high-income Asian coun-
tries, and it would be interesting to compare their results
to those of low- and middle-income Asian countries,
where the prevalence of DED and dyslipidemia differ.
In conclusion, after adjustment for systemic and socio-
economic parameters, DED in this Korean population
was associated with high serum cholesterol level but not
with LDL, or TG levels in female subjects. And HDL
may be a risk factor for DED despite of its cardiovas-
cular protective effect. However, further verification of
both prospective and basic science studies, would be
needed. The results of this study highlight the significance
of eye examinations and lipid profile monitoring in
dyslipidemia patients due to its possible correlation with
the progression of DED. The systemic lipid transporter
system may affect local lipid biosynthesis, although differ-
ently than that in cardiovascular diseases. Further studies
are needed to confirm the exact mechanism and corre-
lation between DED and dyslipidemia.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YHC analyzed the data and wrote the manuscript. HRK and HJS participate in
the execution and analysis of this study. KDH and YKP participate the
statistical analysis. NKS designed and critically revised the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
The National Research Foundation of Korea (2011-0027157), Seoul, Korea,
supported this study.
Author details
1Department of Pediatrics, Incheon St. Mary’s Hospital, College of Medicine,
The Catholic University of Korea, Seoul, South Korea. 2Department of HealthPromotion Center, Seoul St. Mary’s Hospital, College of Medicine, The
Catholic University of Korea, Seoul, South Korea. 3Department of Biostatistics,
The Catholic University of Korea, Seoul, South Korea. 4Department of
Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of
Medicine, The Catholic University of Korea, Seoul, South Korea.
Received: 15 April 2013 Accepted: 27 May 2013
Published: 5 June 2013
References
1. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW: Functional aspects of
the tear film lipid layer. Exp Eye Res 2004, 78:347–360.
2. Butovich IA: Lipidomics of human Meibomian gland secretions:
chemistry, biophysics, and physiological role of Meibomian lipids.
Prog Lipid Res 2011, 50:278–301.
3. Nicolaides N: Skin Lipids II. Lipid class composition of samples from
various species and anatomical sites. J Am Oil Chem Soc 1965, 42:691–702.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults: Executive summary of the third report of the
national cholesterol education program (NCEP) expert panel on
detection, evaluation, and treatment of high blood cholesterol in adults
(adult treatment panel III). JAMA 2001, 285:2486–2497.
5. Cheng AY, Leiter LA: Implications of recent clinical trials for the national
cholesterol education program adult treatment panel III guidelines.
Curr Opin Cardiol 2006, 21:400–404.
6. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA,
Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr: Primary prevention of
acute coronary events with lovastatin in men and women with average
cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary
Atherosclerosis Prevention Study. JAMA 1998, 279:1615–1622.
7. Toth PP: When high is low: raising low levels of high-density lipoprotein
cholesterol. Curr Cardiol Rep 2008, 10:488–496.
8. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S,
Boekholdt SM, Khaw KT, Gudnason V: Triglycerides and the risk of
coronary heart disease: 10,158 incident cases among 262,525
participants in 29 Western prospective studies. Circulation 2007,
115:450–458.
9. Lemp MA: Advances in understanding and managing dry eye disease.
Am J Ophthalmo. 2008, 146:350–356.
10. Moss SE, Klein R, Klein BE: Prevalence of and risk factors for dry eye
syndrome. Arch Ophthalmol 2000, 118:1264–1268.
11. Wang TJ, Wang IJ, Hu CC, Lin HC: Comorbidities of dry eye disease: a
nationwide population-based study. Acta Ophthalmol 2012, 90:663–668.
12. Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW: Association of
dyslipidemia in moderate to severe meibomian gland dysfunction.
Am J Ophthalmol 2010, 150:371–375. e1.
13. Bukhari AA: Associations between the grade of meibomian gland
dysfunction and dyslipidemia. Ophthal Plast Reconstr Surg 2013,
29:101–103.
14. Módulo CM, Machado Filho EB, Malki LT, Dias AC, de Souza JC, Oliveira HC,
Jorge IC, Santos Gomes IB, Meyrelles SS, Rocha EM: The role of
dyslipidemia on ocular surface, lacrimal and meibomian gland structure
and function. Curr Eye Res 2012, 37:300–308.
15. Korea Centers for Disease Control and Prevention: Korean national health
and nutrition examination survey. http://knhanes.cdc.go.kr/.
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of
low-density lipoprotein cholesterol in plasma, without use of the
preparative ultracentrifuge. Clin Chem 1972, 18:499–502.
17. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA,
Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM,
Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA: AHA
guidelines for primary prevention of cardiovascular disease and stroke:
2002 update: consensus panel guide to comprehensive risk reduction
for adult patients without coronary or other atherosclerotic vascular
diseases. American heart association science advisory and coordinating
committee. Circulation 2002, 106:388–391.
18. Rojas R, Aguilar-Salinas CA, Gómez-Pérez FJ, Valles V, Franco A, Olaiz G,
Sepúlveda J, Rull JA: Applicability of the national cholesterol education
program III (NCEP-III) guidelines for treatment of dyslipidemia in a non-
Caucasian population: a Mexican nation-wide survey. Rev Invest Clin 2005,
57:28–37.
Chun et al. Lipids in Health and Disease 2013, 12:84 Page 8 of 8
http://www.lipidworld.com/content/12/1/8419. Butovich IA, Millar TJ, Ham BM: Understanding and analyzing meibomian
lipids–a review. Curr Eye Res 2008, 33:405–420.
20. Deplewski D, Qin K, Ciletti N, Rosenfield RL: Unique mode of lipogenic
activation in rat preputial sebocytes. J Nutr Metab 2011, 2011:163631.
21. Yagyu H, Kitamine T, Osuga J, Tozawa R, Chen Z, Kaji Y, Oka T, Perrey S,
Tamura Y, Ohashi K, Okazaki H, Yahagi N, Shionoiri F, Iizuka Y, Harada K,
Shimano H, Yamashita H, Gotoda T, Yamada N, Ishibashi S: Absence of
ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous
xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 2000,
275:21324–21330.
22. Jang SB, Lee YJ, Lim LA, Park KM, Kwon BJ, Woo JS, Kim YI, Park MS, Kim KH,
Park K: Pharmacokinetic comparison of controlled-release and
immediate-release oral formulations of simvastatin in healthy Korean
subjects: a randomized, open-label, parallel-group, single- and multiple-
dose study. Clin Ther 2010, 32:206–216.
23. Asbell PA, Stapleton FJ, Wickström K, Akpek EK, Aragona P, Dana R, Lemp
MA, Nichols KK: The international workshop on meibomian gland
dysfunction: report of the clinical trials subcommittee. Invest Ophthalmol
Vis Sci 2011, 52:2065–2085.
24. Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A: Prevalence of dry
eye in Bangkok, Thailand. Cornea 2006, 25:1162–1167.
25. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM: Prevalence of dry eye
among an elderly Chinese population in Taiwan: the Shihpai Eye Study.
Ophthalmology 2003, 110:1096–1101.
26. Uchino M, Dogru M, Yagi Y, Goto E, Tomita M, Kon T, Saiki M, Matsumoto Y,
Uchino Y, Yokoi N, Kinoshita S, Tsubota K: The features of dry eye disease
in a Japanese elderly population. Optom Vis Sci 2006, 83:797–802.
27. Jie Y, Xu L, Wu YY, Jonas JB: Prevalence of dry eye among adult Chinese
in the Beijing Eye study. Eye (Lond) 2009, 23:688–693.
doi:10.1186/1476-511X-12-84
Cite this article as: Chun et al.: Total cholesterol and lipoprotein
composition are associated with dry eye disease in Korean women.
Lipids in Health and Disease 2013 12:84.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
